NEW DELHI/MUMBAI, Nov 29 (Reuters) - The Indian Council of Medical Research (ICMR) is assisting an inquiry into an alleged adverse reaction during AstraZeneca's COVID-19 vaccine trial, but has found ...
AstraZeneca AZN reported mixed phase 3 data for datopotamab deruxtecan in lung cancer, but we don’t see the data as having a major impact on the firm’s fair value or wide moat. The cancer treatment ...
The woman who experienced a severe adverse reaction after receiving a COVID-19 vaccine while participating in AstraZeneca's U.K. trial had transverse myelitis, according to an internal safety report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results